Research Grants (Inflammation & Immunology focus)

Research Grants (Inflammation & Immunology focus) is sponsored by Pfizer. Pfizer supports independent initiatives by the global healthcare community to improve patient outcomes in areas of unmet medical need that align with Pfizer’s medical and/or scientific strategies, including Inflammation & Immunology.

Competitive Grants Program | Pfizer Funding Global Health Through Grants Competitive Grants Program Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Implementing Shared Decision Making in Hemophilia Patient Care Release Date: May 26, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Rare Disease USA September 17, 2026 Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals Release Date: June 24, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Vaccines Japan September 30, 2026 Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases Release Date: June 26, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Vaccines Japan September 30, 2026 Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer Release Date: July 1, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Oncology USA September 24, 2026 The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults Release Date: July 6, 2026 Review Process: Expert Review Panel View RFP (PDF) Research Vaccines Italy October 19, 2026 Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations Release Date: July 6, 2026 Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Vaccines Italy October 19, 2026 2026 VAC US SMFM Maternal RSV QI Release Date: July 30, 2026 Partner: Society for Maternal Fetal Medicine Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Vaccines USA September 17, 2026 Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC) Release Date: July 30, 2026 Review Process: Expert Review Panel View RFP (PDF) Education Oncology All September 6, 2026 Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting Professorship Release Date: August 10, 2026 Partner: Prostate Cancer Foundation Review Process: Expert Review Panel View RFP (PDF) Education Oncology USA September 9, 2026 Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement Project Release Date: August 13, 2026 Partner: American Academy of Family Physicians Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Internal Medicine USA September 30, 2026 Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Pneumococcal Disease Prevention Release Date: April 11, 2012 Review Process: View RFP (PDF) Release Date: May 8, 2012 Review Process: View RFP (PDF) Release Date: June 28, 2012 Review Process: View RFP (PDF) Pharmacy Pneumococcal Disease Prevention Release Date: June 28, 2012 Review Process: View RFP (PDF) Release Date: July 2, 2012 Review Process: View RFP (PDF) Non-Small Cell Lung Cancer Release Date: July 10, 2012 Review Process: View RFP (PDF) Cardiovascular Risk in Rheumatoid Arthritis Release Date: July 25, 2012 Review Process: View RFP (PDF) Release Date: July 26, 2012 Review Process: View RFP (PDF) Adult Pneumococcal Disease Prevention Release Date: August 29, 2012 Review Process: View RFP (PDF) Prevention of Stroke in Women Release Date: September 13, 2012 Review Process: View RFP (PDF) Oncology Educational Needs Assessments Release Date: October 22, 2012 Review Process: View RFP (PDF) Release Date: November 1, 2012 Review Process: View RFP (PDF)